Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

Author:

Bartos Laura M,Kirchleitner Sabrina VORCID,Kolabas Zeynep IlginORCID,Quach StefanieORCID,Blobner JensORCID,Mueller Stephan AORCID,Ulukaya Selin,Hoeher Luciano,Horvath IzabelaORCID,Wind-Mark Karin,Holzgreve AdrienORCID,Ruf Viktoria C,Gold Lukas,Kunze Lea H,Kunte Sebastian T,Beumers Philipp,Antons Melissa,Zatcepin Artem,Briel Nils,Hoermann Leonie,Messerer Denise,Bartenstein Peter,Riemenschneider Markus J,Lindner Simon,Ziegler Sibylle,Herms JochenORCID,Lichtenthaler Stefan FORCID,Ertürk AliORCID,Tonn Joerg C,Baumgarten Louisa vonORCID,Albert Nathalie L,Brendel MatthiasORCID

Abstract

AbstractVarious cellular sources hamper interpretation of positron-emission-tomography (PET) biomarkers in the tumor microenvironment (TME). We developed immunomagnetic cell sorting afterin vivoradiotracer injection (scRadiotracing) in combination with 3D-histology via tissue clearing to dissect the cellular allocation of PET signals in the TME. In SB28 glioblastoma mice, translocator protein (TSPO) radiotracer uptake per tumor cell was higher compared to tumor-associated microglia/macrophages (TAMs). Cellular radiotracer uptake was validated by proteomics and confirmed forin vitrosamples of patients with glioblastoma. Regional agreement between PET signals and single cell tracer uptake predicted the individual cell distribution in 3D-histology. In consideration of cellular tracer uptake and cell type abundance, tumor cells were the main contributor to TSPO enrichment in glioblastoma, however proteomics identified potential PET targets highly specific for TAMs. Combining cellular tracer uptake measures with 3D-histology facilitates precise allocation of complex PET signal sources and will serve to validate novel TAM-specific radioligands.

Publisher

Cold Spring Harbor Laboratory

Reference64 articles.

1. The updated landscape of tumor microenvironment and drug repurposing;Signal Transduction and Targeted Therapy,2020

2. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

3. Potential PET tracers for imaging of tumor-associated macrophages;EJNMMI Radiopharmacy and Chemistry,2022

4. Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial;Nature Medicine,2022

5. Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians;Neurooncol Pract,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3